Insider Selling: Quantum-Si (NASDAQ:QSI) CEO Sells $15,308.68 in Stock

Key Points

• Quantum-Si CEO Jeffrey Hawkins sold 20,143 shares at an average price of $0.76, generating $15,308.68; he also sold 9,709 shares the following day and still owns approximately 3.65 million shares.
• QSI shares fell 3.3% to $0.76, near the stock’s 52-week low of $0.69, while the company reported a quarterly loss of $0.11 per share and $0.34 million in revenue.
• Analyst sentiment is mixed, with one Buy, one Hold and one Sell rating, resulting in a consensus Hold rating and a $1.00 average price target.

Quantum-Si Incorporated (NASDAQ:QSI - Get Free Report) CEO Jeffrey Hawkins sold 20,143 shares of the stock in a transaction on Monday, September 21st. The shares were sold at an average price of $0.76, for a total value of $15,308.68. Following the completion of the transaction, the chief executive officer directly owned 3,649,659 shares of the company's stock, valued at approximately $2,773,740.84. This represents a 0.55% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Jeffrey Alan Hawkins also recently made the following trade(s):

• On Tuesday, September 22nd, Jeffrey Hawkins sold 9,709 shares of Quantum-Si stock. The shares were sold at an average price of $0.76, for a total value of $7,378.84.

Quantum-Si Trading Down 3.3%

QSI traded down $0.03 on Wednesday, hitting $0.76. 1,450,049 shares of the company's stock were exchanged, compared to its average volume of 1,472,687. Quantum-Si Incorporated has a fifty-two week low of $0.69 and a fifty-two week high of $3.10. The stock has a market cap of $166.06 million, a price-to-earnings ratio of -1.65 and a beta of 3.25. The firm has a 50-day moving average price of $0.77 and a 200-day moving average price of $0.88.

Quantum-Si (NASDAQ:QSI - Get Free Report) last posted its quarterly earnings results on Thursday, August 13th. The company reported ($0.11) earnings per share for the quarter, hitting the consensus estimate of ($0.11). Quantum-Si had a negative net margin of 6,138.26% and a negative return on equity of 47.12%. The firm had revenue of $0.34 million for the quarter, compared to the consensus estimate of $0.30 million. On average, equities analysts predict that Quantum-Si Incorporated will post -0.47 EPS for the current year.

Wall Street Analyst Weigh In

QSI has been the subject of a number of analyst reports. Weiss Ratings cut Quantum-Si from a "sell (d-)" rating to a "sell (e+)" rating in a report on Wednesday, September 9th. Wall Street Zen raised shares of Quantum-Si from a "sell" rating to a "hold" rating in a research report on Saturday, September 12th. Finally, Alliance Global Partners reissued a "buy" rating on shares of Quantum-Si in a research note on Friday, August 14th. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $1.00.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. Renaissance Technologies LLC purchased a new position in shares of Quantum-Si during the first quarter worth $91,000. WINTON GROUP Ltd acquired a new position in Quantum-Si during the 2nd quarter worth about $67,000. Green Alpha Advisors LLC acquired a new position in Quantum-Si during the 2nd quarter worth about $41,000. Corient Private Wealth LP purchased a new position in Quantum-Si during the 2nd quarter valued at about $34,000. Finally, Hollencrest Capital Management boosted its holdings in Quantum-Si by 301.1% during the 1st quarter. Hollencrest Capital Management now owns 40,111 shares of the company's stock valued at $31,000 after acquiring an additional 30,111 shares during the period. 39.90% of the stock is currently owned by institutional investors and hedge funds.

Quantum-Si Company Profile

Quantum-Si Incorporated NASDAQ: QSI is a life sciences technology company focused on advancing proteomics, the study of proteins and their roles in biological systems. The company develops tools intended to help researchers identify and analyze proteins at the single-molecule level, supporting applications in drug discovery, translational research and precision medicine.

Its primary offering is the Platinum platform, which combines an automated instrument, proprietary sequencing technology, consumables and software for protein analysis.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.